Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (924) Arrow Down
Filter Results: (924) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (1,277)
    • People  (5)
    • News  (171)
    • Research  (924)
    • Events  (6)
    • Multimedia  (12)
  • Faculty Publications  (756)

Show Results For

  • All HBS Web  (1,277)
    • People  (5)
    • News  (171)
    • Research  (924)
    • Events  (6)
    • Multimedia  (12)
  • Faculty Publications  (756)
← Page 36 of 924 Results →
Sort by

Are you looking for?

→Search All HBS Web
  • February 2000
  • Case

Merck-Medco (B)

By: V. Kasturi Rangan
Keywords: Pharmaceutical Industry
Citation
Find at Harvard
Related
Rangan, V. Kasturi. "Merck-Medco (B)." Harvard Business School Case 500-078, February 2000.
  • February 1987 (Revised April 1987)
  • Case

Eli Lilly and Co. (A)

By: William J. Bruns Jr.
Keywords: Pharmaceutical Industry
Citation
Find at Harvard
Related
Bruns, William J., Jr. "Eli Lilly and Co. (A)." Harvard Business School Case 187-064, February 1987. (Revised April 1987.)
  • March 1999 (Revised June 2000)
  • Case

Eli Lilly: The Evista Project

By: Steven C. Wheelwright and Matt Verlinden
Describes the creation and operation of the initial two heavyweight teams for new drug development and launch. The primary focus is on one of the teams, Evista, although comparisons to the other team, Zyprexa, are included. Lilly must decide the next phase (postlaunch)... View Details
Keywords: Projects; Groups and Teams; Operations; Management Teams; Product Development; Transition; Product Design; Business Startups; Business Plan; Product Launch; Competition; Service Operations; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Wheelwright, Steven C., and Matt Verlinden. "Eli Lilly: The Evista Project." Harvard Business School Case 699-016, March 1999. (Revised June 2000.)
  • September 1993
  • Supplement

Manufacturing at ALZA: The Right Prescription? (C)

By: Dorothy A. Leonard
ALZA, a drug delivery company, considers marketing its own and other companies' products. The primary issue is whether to build an internal sales force focused on a few niche markets, to finance a sales force through alliances, or to acquire a marketing company. View Details
Keywords: Mergers and Acquisitions; Product Marketing; Alliances; Research and Development; Salesforce Management; Business Strategy; Pharmaceutical Industry
Citation
Find at Harvard
Related
Leonard, Dorothy A. "Manufacturing at ALZA: The Right Prescription? (C)." Harvard Business School Supplement 694-021, September 1993.
  • September 1983 (Revised November 1984)
  • Case

Syntex Laboratories (B)

The recommendations of the consultants require a number of assumptions and modifications to be implemented by Syntex Labs. Presents the initial implementation plan of the company. View Details
Keywords: Organizational Change and Adaptation; Strategic Planning; Salesforce Management; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Clarke, Darral G. "Syntex Laboratories (B)." Harvard Business School Case 584-034, September 1983. (Revised November 1984.)
  • July 28, 2004
  • Article

Generic Dispensing and Substitution in Mail and Retail Pharmacies

By: Marta Wosinska and Robert S. Huckman
Keywords: Health; Sales; Pharmaceutical Industry
Citation
Find at Harvard
Read Now
Related
Wosinska, Marta, and Robert S. Huckman. "Generic Dispensing and Substitution in Mail and Retail Pharmacies." Health Affairs (July 28, 2004): W4–409 – W4–416.
  • August 1995 (Revised June 1997)
  • Case

Hillcrest Research Associates, Inc.

Hillcrest designs and administers testing procedures for drugs to determine whether they pass FDA specifications. As the company grows, it encounters problems with information technology and with the clinical research associates, who feel pressured to report more... View Details
Keywords: Growth Management; Information Technology; Health Testing and Trials; Pharmaceutical Industry
Citation
Find at Harvard
Related
Barnes, Louis B. "Hillcrest Research Associates, Inc." Harvard Business School Case 496-021, August 1995. (Revised June 1997.)
  • May 1992
  • Teaching Note

Amgen, Inc.: Planning the Unplannable, Teaching Note

By: Nitin Nohria
Teaching Note for (9-492-052). View Details
Keywords: Pharmaceutical Industry
Citation
Purchase
Related
Nohria, Nitin. "Amgen, Inc.: Planning the Unplannable, Teaching Note." Harvard Business School Teaching Note 492-054, May 1992.
  • November 2006
  • Case

Competitive Headaches (A): The Analgesic Wars

By: Dennis A. Yao
Addresses the problem of competing with a me-too consumer product. Focuses on Bristol-Meyers' 1975 strategy for introducing a competitor to Tylenol in the analgesic market. View Details
Keywords: Market Entry and Exit; Competition; Competitive Advantage; Pharmaceutical Industry; Pharmaceutical Industry
Citation
Educators
Related
Yao, Dennis A. "Competitive Headaches (A): The Analgesic Wars." Harvard Business School Case 707-489, November 2006.
  • November 1999
  • Teaching Note

drugstore.com TN

By: Richard L. Nolan
Teaching Note for (9-300-036). View Details
Keywords: Pharmaceutical Industry; Pharmaceutical Industry
Citation
Purchase
Related
Nolan, Richard L. "drugstore.com TN." Harvard Business School Teaching Note 300-057, November 1999.
  • 07 Aug 2009
  • What Do You Think?

Why Can’t Americans Get Health Care Right?

above are numerous in a channel that includes, in your comments, food and tobacco producers of unhealthy products (Christy Hitchens, Tom Dolembo); lifestyle equipment and service providers; developers and manufacturers of high-cost View Details
Keywords: by Jim Heskett; Health
  • 22 Apr 2014
  • First Look

First Look: April 22

constraints. Download working paper: https://www.hbs.edu/faculty/Pages/download.aspx?name=14-097.pdf The Organizational and Geographic Drivers of Absorptive Capacity: An Empirical Analysis of Pharmaceutical R&D Laboratories By:... View Details
Keywords: Sean Silverthorne
  • 20 Nov 2006
  • Research & Ideas

Open Source Science: A New Model for Innovation

problems that were posted? A: Innovations happen at the intersection of disciplines. People have talked about that a lot and I think we're providing some systematic evidence now with this study. Another example is that a pharmaceutical... View Details
Keywords: by Martha Lagace
  • 18 Jul 2018
  • Research & Ideas

No More General Tso's? A Threat to 'Knowledge Recombination'

pharmaceutical companies, which had been flying in scientists from China and India who, like Cohly, brought knowledge of native herbs. Some pharma companies were able to earn exemptions from the H1-B limits. Choudhury and Kim used this... View Details
Keywords: by Michael Blanding; Health; Food & Beverage; Accounting
  • 26 Jun 2000
  • Research & Ideas

What’s an Internet Business Model? Ask a Health Care Professional

out how to get into a clinical trial to try an experimental drug. For their part, physicians are often befuddled by difficult cases that don't respond to traditional therapies. And pharmaceutical companies, at the same time, are anxious... View Details
Keywords: by Martha Lagace; Health
  • 30 Apr 2001
  • Research & Ideas

Entering the Age of Alliances

competencies of each partner and create two-way value is evidenced by, among others, the collaboration between The College Fund (UNCF) and Merck. UNCF, the largest and oldest minority educational assistance organization in the United States, and Merck, a leading global... View Details
Keywords: by James Austin
  • April 2024 (Revised November 2024)
  • Case

Moderna: Pioneering a People Platform to Accelerate Science Innovation

By: Tatiana Sandino, Emil Dy and Samuel Grad
Moderna was founded in 2010 to explore how messenger ribonucleic acid (mRNA) could be used to create breakthrough medicines by encoding instructions for the body to create antibodies. When Stéphane Bancel (HBS 2000) took over in 2011, he bet on the potential of this... View Details
Keywords: Disruptive Innovation; Talent and Talent Management; Selection and Staffing; AI and Machine Learning; Digital Strategy; Innovation and Management; Leadership Development; Management Practices and Processes; Management Systems; Organizational Culture; Performance Evaluation; Alignment; Employee Relationship Management; Science-Based Business; Expansion; Pharmaceutical Industry; Pharmaceutical Industry; United States
Citation
Educators
Purchase
Related
Sandino, Tatiana, Emil Dy, and Samuel Grad. "Moderna: Pioneering a People Platform to Accelerate Science Innovation." Harvard Business School Case 124-091, April 2024. (Revised November 2024.)
  • November 2020
  • Teaching Note

Valuing Celgene's CVR

By: Benjamin C. Esty and Daniel Fisher
Teaching Note for HBS Case No. 221-031. When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA)... View Details
Keywords: Mergers and Acquisitions; Valuation; Value; Judgments; Decision Making; Cash Flow; Financial Instruments; Cognition and Thinking; Pharmaceutical Industry; Pharmaceutical Industry; United States
Citation
Purchase
Related
Esty, Benjamin C., and Daniel Fisher. "Valuing Celgene's CVR." Harvard Business School Teaching Note 221-036, November 2020.
  • Article

Trends and Predictors of Biomedical Research Quality, 1990–2015: A Meta-Research Study

By: Maryaline Catillon
Keywords: Biomedical Research; R&D; Innovation; Technology; Drug Trials; RCT; Health; Healthcare; Health Care And Treatment; Health Care Policy; Innovation and Invention; Innovation Strategy; Research and Development; Technological Innovation; Pharmaceutical Industry; Pharmaceutical Industry
Citation
Read Now
Related
Catillon, Maryaline. "Trends and Predictors of Biomedical Research Quality, 1990–2015: A Meta-Research Study." BMJ Open 9, no. 9 (September 2019).
  • September 2012
  • Case

SCMS: Battling HIV/AIDS in Africa

By: Ananth Raman, Noel Watson, Santiago Kraiselburd and Emmanuel Akili
In 2005, USAID and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), created the Supply Chain Management System (SCMS) to procure and distribute essential medicines and supplies; provide technical assistance to transform existing supply chains; and... View Details
Keywords: HIV; AIDS; Procurement Coordination; Developing Countries; Healthcare; Public Health; Ethiopia; Supply Systems For Healthcare Delivery In Developing Countries; Healthcare Logistics Industry; Health Disorders; Health Care and Treatment; Service Delivery; Supply Chain Management; Logistics; Developing Countries and Economies; Programs; Transition; Strategy; Pharmaceutical Industry; Pharmaceutical Industry; Ethiopia; Africa
Citation
Educators
Purchase
Related
Raman, Ananth, Noel Watson, Santiago Kraiselburd, and Emmanuel Akili. "SCMS: Battling HIV/AIDS in Africa." Harvard Business School Case 613-023, September 2012.
  • ←
  • 36
  • 37
  • …
  • 46
  • 47
  • →

Are you looking for?

→Search All HBS Web
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.